<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="462">
  <stage>Registered</stage>
  <submitdate>8/09/2005</submitdate>
  <approvaldate>30/09/2005</approvaldate>
  <actrnumber>ACTRN12605000563662</actrnumber>
  <trial_identification>
    <studytitle>Bowel recovery after colorectal surgery: A comparison of patient contolled analgesia with tramadol versus morphine</studytitle>
    <scientifictitle>Bowel recovery after colorectal surgery: A comparison of patient contolled analgesia with tramadol versus morphine</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Return of normal gastrointestinal function</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Post-operative analgesia via PCA containing either tramadol 600mg in 30mls n.saline or morphine 60mg in 30mls n. saline. PCA commenced in recovery and programmed to deliver an initial loading dose of 0.1ml study drug/kg body weight. Patient demand boluses then set at 0.5ml study drug with 5minute lockout and no dose limit. Bolus dose can be inreased to 1ml if analgesia inadequate. If  increase in dose remains inadequate then patient will be withdrawn from trial and receive alternative analgesia as per Acute Pain Service protocol. Study duration &lt; 1 week for each subject. Computer programme randomisation by pharmacy.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time to first flatus</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first bowel motion.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA 1-3, elective colorectal surgery.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with known gastrointestinal tract disorders, previous abdominal radiotherapy, clinically relevant liver or renal impairment, chronic pre-op opiod use, patients unsuitable for PCA, planned epidural analgesia.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Computer software, with no blocking or stratification</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>12/10/2001</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>36</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Stephan Schug</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia &amp; Pain Medicine Royal Perth Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Shauna Fatovich</name>
      <address>Department Anaesthesia and Pain Medicine
Royal Perth Hospital
Wellington Street
Perth WA 6000</address>
      <phone>+61 8 92241036</phone>
      <fax />
      <email>shauna.fatovich@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Stephan Schug</name>
      <address>Pharmacology Unit
School of Medicine and Pharmacology
Royal Perth Hospital
GPO Box X2213
Perth WA 6847</address>
      <phone>+61 8 92240201</phone>
      <fax />
      <email>schug@cyllene.uwa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>